Status:
COMPLETED
Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Resectable Esophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Despite the availability of several preoperative diagnostic techniques, accurate pretreatment staging of esophageal cancer (EC) remains challenging. Therefore, The investigators evaluated the prognost...
Eligibility Criteria
Inclusion
- \> 18 years
- resectable esophageal cancer
Exclusion
- \< 18 years
- esophageal cancer with preoperative distant metastases
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT01858805
Start Date
April 1 2010
End Date
April 1 2014
Last Update
November 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Hamburg-Eppendorf
Hamburg, Germany, 20246